China Universal Asset Management »

Arrowhead Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $682k 24k 28.60
2023-12-31 $380k 12k 30.60
2023-09-30 $74k 2.8k 26.87
2023-06-30 $50k 1.4k 35.66
2023-03-31 $37k 1.5k 25.40
2022-12-31 $44k 1.1k 40.56
2022-09-30 $33k 992 33.27

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
FMR
Artal Group
Geode Capital Management
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Credit Suisse
Northern Trust
Rokos Capital Management
Pictet Asset Management Holding SA
Morgan Stanley
venBio Select Advisor
Bank of New York Mellon
Goldman Sachs Group

View all funds holding Arrowhead Pharmaceuticals